Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tumorspheres in Metastatic Colorectal Cancer
NCT03251612Phase 2Completed
- Sponsor
- Vejle Hospital
- Start
- Sep 2017
- Primary completion
- Aug 2021
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial in colorectal cancer (metastatic) (mCRC), sponsored by Vejle Hospital. Primary endpoint: Progression-Free Survival Rate at 8 weeks. Started Sep 2017; status: completed.
02
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT03251612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03251612.